Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$204.13 - $302.4 $9 Million - $13.3 Million
44,100 Added 128.16%
78,509 $16.8 Million
Q1 2022

May 13, 2022

BUY
$255.51 - $362.11 $1.87 Million - $2.65 Million
7,309 Added 26.97%
34,409 $9.77 Million
Q4 2021

Feb 11, 2022

SELL
$351.38 - $448.68 $4.64 Million - $5.92 Million
-13,200 Reduced 32.75%
27,100 $10.2 Million
Q3 2021

Nov 12, 2021

SELL
$372.64 - $458.3 $6.15 Million - $7.56 Million
-16,500 Reduced 29.05%
40,300 $16.6 Million
Q2 2021

Aug 13, 2021

SELL
$294.17 - $371.65 $36.3 Million - $45.9 Million
-123,389 Reduced 68.48%
56,800 $21 Million
Q1 2021

May 13, 2021

SELL
$249.67 - $299.48 $63.5 Million - $76.2 Million
-254,300 Reduced 58.53%
180,189 $52.2 Million
Q4 2020

Feb 10, 2021

SELL
$222.0 - $252.62 $62.9 Million - $71.5 Million
-283,190 Reduced 39.46%
434,489 $109 Million
Q3 2020

Nov 13, 2020

SELL
$175.56 - $226.45 $55.7 Million - $71.8 Million
-317,100 Reduced 30.64%
717,679 $163 Million
Q2 2020

Aug 13, 2020

SELL
$118.84 - $189.72 $36 Million - $57.4 Million
-302,609 Reduced 22.63%
1,034,779 $180 Million
Q1 2020

May 14, 2020

SELL
$98.9 - $178.34 $8.92 Million - $16.1 Million
-90,191 Reduced 6.32%
1,337,388 $169 Million
Q4 2019

Feb 13, 2020

SELL
$126.05 - $152.76 $3.67 Million - $4.45 Million
-29,104 Reduced 2.0%
1,427,579 $218 Million
Q3 2019

Nov 13, 2019

SELL
$125.07 - $143.67 $26 Million - $29.9 Million
-207,817 Reduced 12.49%
1,456,683 $193 Million
Q2 2019

Aug 12, 2019

SELL
$123.4 - $148.55 $27.3 Million - $32.9 Million
-221,200 Reduced 11.73%
1,664,500 $236 Million
Q1 2019

May 14, 2019

BUY
$104.82 - $146.73 $900,508 - $1.26 Million
8,591 Added 0.46%
1,885,700 $274 Million
Q4 2018

Feb 13, 2019

BUY
$105.09 - $137.23 $197 Million - $258 Million
1,877,109 New
1,877,109 $212 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.84B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.